Difference between revisions of "Actinium Ac 225 lintuzumab (Actimab-A)"
Jump to navigation
Jump to search
Warner-admin (talk | contribs) m (Text replacement - "Category:Antibody medications" to "") |
m |
||
| Line 1: | Line 1: | ||
| − | =Mechanism of action= | + | ==Mechanism of action== |
Monoclonal antibody directed against CD33 with a radioactive agent attached. | Monoclonal antibody directed against CD33 with a radioactive agent attached. | ||
| − | =Preliminary data= | + | ==Preliminary data== |
| − | ==[[Acute myeloid leukemia]]== | + | ===[[Acute myeloid leukemia]]=== |
| + | |||
| + | ==Also know as== | ||
| + | *'''Brand name:''' Actimab-A | ||
[[Category:Drugs]] | [[Category:Drugs]] | ||
Revision as of 14:20, 12 December 2020
Mechanism of action
Monoclonal antibody directed against CD33 with a radioactive agent attached.
Preliminary data
Acute myeloid leukemia
Also know as
- Brand name: Actimab-A